Loading...
XNYS
FTV
Market cap17bUSD
Oct 08, Last price  
56.42USD
1D
-0.18%
1Q
-9.29%
Jan 2017
66.83%
IPO
80.60%
Name

Fortive Corp

Chart & performance

D1W1MN
XNYS:FTV chart
P/E
29.42
P/S
3.31
EPS
1.92
Div yield, %
0.43%
Shrs. gr., 5y
-2.31%
Rev. gr., 5y
2.10%
Revenues
5.14b
-17.48%
5,785,300,0005,961,900,0006,337,200,0006,178,800,0006,224,300,0005,756,100,0006,452,700,0004,563,900,0004,634,400,0005,254,700,0005,825,700,0006,065,300,0006,231,800,0005,142,599,999
Net income
579m
-30.46%
763,700,000830,900,000883,400,000863,800,000872,300,0001,044,500,0002,913,800,000738,900,0001,613,300,000608,400,000755,200,000865,800,000832,900,000579,200,000
CFO
1.08b
-29.05%
944,000,0001,030,200,000946,700,0001,009,000,0001,136,900,0001,176,400,0001,344,400,0001,271,400,0001,436,700,000961,100,0001,303,200,0001,353,600,0001,526,800,0001,083,200,000
Dividend
Sep 04, 20260.07 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded by James A. Lico and Stacey A. Walker on November 10, 2015 and is headquartered in Everett, WA.

Related entities

Subsidiaries (4)
ADVANCED STERILIZATION PRODUCTS INDIA PRIVATE LIMITED
Fortive Retirement Savings Plan and Fortive Union Retirement Savings Plan Master Trust
FLUKE TECHNOLOGIES PRIVATE LIMITED
TEKTRONIX (INDIA) PRIVATE LIMITED

Key people

Independent Chairman of the Board · since 2025
Tamara Newcombe
President and Chief Executive Officer of the Precision Technologies · since 2025
President, Chief Executive Officer, Director · since 2025
Chief Financial Officer, Senior Vice President · since 2025
Jonathan Schwarz
Senior Vice President - Corporate Development · since 2021
Edward Simmons
Senior Vice President - Strategy · since 2021
Peter Underwood
Senior Vice President, General Counsel · since 2016
Independent Director · since 2023
Daniel Comas
Independent Director · since 2021
Independent Director · since 2020
Wright Lassiter
Independent Director · since 2022
Kate Mitchell
Independent Director · since 2016
Gregory J. Moore
Independent Director · since 2025
Jeannine Sargent
Independent Director · since 2019
IPO date
Jun 13, 2016
Employees
25,000
Domiciled in
US
Incorporated in
US
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
6920 Seaway Boulevard
Everett, WA 98203
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT